MAPK7 Antikörper (pThr218, Tyr220)
-
- Target Alle MAPK7 Antikörper anzeigen
- MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
-
Bindungsspezifität
- AA 213-224, pThr218, Tyr220
-
Reaktivität
- Human
-
Wirt
-
Schaf
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAPK7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Recognizes human phospho-BMK1/Erk5 (Thr218, Tyr220), Mr ~110kD. Predicted to cross-react with mouse and rat based on sequence homology.
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide corresponding to amino acids 213-224 of human BMK1/Erk5 (HQYFM[pT]E[pY]VATR), KLH-conjugated. The immunizing sequence is identical in mouse, 9/12aa identical in rat.
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product MAPK7 Primärantikörper
-
-
- Applikationshinweise
-
Approved: WB
Usage: Suitable for use in Western Blot. Western Blot: 1-:250-1:500 detects phospho-BMK1/Erk5 (Thr218, Tyr220) in RIPA lysates from HeLa cells treated with sorbitol. Lysates from untreated or sorbitol-treated HeLa cells were resolved by electrophoresis, transferred to nitrocellulose and probed with either anti-phospho-BMK1/Erk5 (Thr218, Tyr220) (1:500) or anti-BMK1/Erk5 (1:1000). Proteins were visualized using a goat anti-rabbit secondary antibody conjugated to HRP and a chemiluminescence detection system (BMK1/Erk5 or phospho- BMK1/Erk5 (110kD).
Not recommended for: IHC-P - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 100 mM Tris-glycine, pH 7.4, 0.15 M sodium chloride, 0.05 % sodium azide, 30 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
- Target
- MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
- Andere Bezeichnung
- MAPK7 / ERK5 (MAPK7 Produkte)
- Synonyme
- BMK1 antikoerper, ERK4 antikoerper, ERK5 antikoerper, PRKM7 antikoerper, Erk5-T antikoerper, ATMPK7 antikoerper, F8D23.5 antikoerper, F8D23_5 antikoerper, MAP kinase 7 antikoerper, Bmk1 antikoerper, Erk5 antikoerper, Prkm7 antikoerper, ERK-5 antikoerper, bmk1 antikoerper, erk4 antikoerper, mapk7 antikoerper, prkm7 antikoerper, mitogen-activated protein kinase 7 antikoerper, MAP kinase 7 antikoerper, mitogen-activated protein kinase 7 L homeolog antikoerper, MAPK7 antikoerper, Mapk7 antikoerper, MPK7 antikoerper, mapk7.L antikoerper
- Hintergrund
-
Name/Gene ID: MAPK7
Subfamily: MAPK
Family: Protein Kinase
Synonyms: MAPK7, Big MAP kinase 1, BMK-1, Erk4, ERK5, MAPK 7, PRKM7, BMK1, BMK1 kinase, ERK-5, MAP kinase 7 - Gen-ID
- 5598
- UniProt
- Q13164
- Pathways
- MAPK Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, cAMP Metabolic Process, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling
-